跳轉至內容
Merck
全部照片(1)

重要文件

05-611

Sigma-Aldrich

抗磷酸化-VASP (Ser239) 抗体,克隆16C2

clone 16C2, Upstate®, from mouse

登入查看組織和合約定價


About This Item

分類程式碼代碼:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物源

mouse

品質等級

抗體表格

purified immunoglobulin

抗體產品種類

primary antibodies

無性繁殖

16C2, monoclonal

物種活性

mouse, rat, human

製造商/商標名

Upstate®

技術

flow cytometry: suitable
immunocytochemistry: suitable
western blot: suitable

同型

IgG1κ

NCBI登錄號

UniProt登錄號

運輸包裝

wet ice

目標翻譯後修改

phosphorylation (pSer239)

基因資訊

human ... VASP(7408)

特異性

基于序列同源性,预计该抗体也会与犬和牛发生交叉反应。
磷酸化VASP

免疫原

磷酸化肽,对应于人磷酸化VASP(RKV[pS]KQE)的236-242位氨基酸

應用

研究子类别
细胞骨架信号转导
研究类别
信号传导
该抗磷酸化VASP (Ser239)抗体,克隆16C2经过验证可用在FC、WB、IC中,检测磷酸化VASP (Ser239)。

品質

通过免疫印迹对CTLL细胞的RIPA裂解液进行了常规评估

標靶描述

50kDa

外觀

100 µg来自无血清细胞培养上清液的小鼠IgG1,通过亲硫吸附和尺寸排阻色谱法纯化。 从1 ml PBS、0.1%叠氮化钠、PEG和蔗糖中冻干。 冻干粉末。用100 µL H2O复溶(15 min,RT),使最终浓度为1 mg/mL。 储存于 -20°C。
亲硫吸附色谱
形式:纯化

儲存和穩定性

在-20°C下可保存2年

法律資訊

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

免責聲明

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

未找到適合的產品?  

試用我們的產品選擇工具.

儲存類別代碼

10 - Combustible liquids


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells.
Bergandi, L; Silvagno, F; Russo, I; Riganti, C; Anfossi, G; Aldieri, E; Ghigo, D; Trovati et al.
Arteriosclerosis, Thrombosis, and Vascular Biology null
I Kishimoto et al.
Journal of neuroendocrinology, 20(11), 1213-1223 (2008-08-30)
Cyclic GMP (cGMP) is known to play important roles for neuronal development and neurite pathfinding. However, the regulatory mechanism that governs the synthesis of cGMP in the nervous system is not well defined. In the present study, we examined the
A Mülsch et al.
Circulation, 103(17), 2188-2194 (2001-05-23)
Chronic in vivo treatment with nitroglycerin (NTG) induces tolerance to nitrates and cross-tolerance to nitrovasodilators and endothelium-derived nitric oxide (NO). We previously identified increased vascular superoxide formation and reduced NO bioavailability as one causal mechanism. It is still controversial whether
Eberhard Schulz et al.
Circulation, 105(10), 1170-1175 (2002-03-13)
In experimental animal models, long-term in vivo treatment with nitroglycerin (NTG) induces both endothelial dysfunction and tolerance to nitrates. However, it is still controversial whether nitrate tolerance in humans is associated with both endothelial dysfunction and impaired vascular response to
Jonel Trebicka et al.
Hepatology (Baltimore, Md.), 47(4), 1264-1276 (2008-03-06)
In cirrhosis, splanchnic vasodilation contributes to portal hypertension, subsequent renal sodium retention, and formation of ascites. Urotensin II(U-II) is a constrictor of large conductive vessels. Conversely, it relaxes mesenteric vessels, decreases glomerular filtration, and increases renal sodium retention. In patients

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務